| Medical and Health Sciences | Lifetime | 621 | FI 4 | 99.97 |
| Oncology | Lifetime | 140 | FI 2 | 99.77 |
| Cancer Research | Lifetime | 75 | FI 1 | 99.62 |
| Gastroenterology | Lifetime | 31 | FI 1 | 99.70 |
| Pulmonary and Respiratory Medicine | Lifetime | 450 | FI 1 | 99.41 |
| Pathology and Forensic Medicine | Lifetime | 318 | FI 4 | 98.82 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 600 | FI 2 | 98.46 |
| Gastroenterology | 2021-2025 | 84 | FI 1 | 93.88 |
| Oncology | 2021-2025 | 674 | FI 3 | 89.81 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 816 | FI 3 | 80.17 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 4 | FI 1 | 99.95 |
| Gastrointestinal disorders and treatments | Lifetime | 16 | FI 1 | 99.87 |
| Gastric Cancer Management and Outcomes | Lifetime | 63 | FI 1 | 99.76 |
| HER2/EGFR in Cancer Research | Lifetime | 58 | FI 1 | 99.68 |
| Breast Cancer Treatment Studies | Lifetime | 79 | FI 1 | 99.72 |
| Sarcoma Diagnosis and Treatment | Lifetime | 88 | FI 1 | 99.57 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 35 | FI 1 | 99.37 |
| Cancer Genomics and Diagnostics | Lifetime | 204 | FI 2 | 99.56 |
| Cancer Treatment and Pharmacology | Lifetime | 175 | FI 1 | 99.45 |
| Lymphoma Diagnosis and Treatment | Lifetime | 251 | FI 1 | 99.23 |
| Genetic factors in colorectal cancer | Lifetime | 249 | FI 5 | 98.92 |
| Angiogenesis and VEGF in Cancer | Lifetime | 185 | FI 3 | 98.74 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 647 | FI 3 | 98.92 |
| Breast Lesions and Carcinomas | Lifetime | 173 | FI 1 | 98.58 |
| Vascular Tumors and Angiosarcomas | Lifetime | 106 | FI 2 | 98.32 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 453 | FI 1 | 97.62 |
| Peptidase Inhibition and Analysis | Lifetime | 851 | FI 12 | 97.33 |
| Thyroid Cancer Diagnosis and Treatment | Lifetime | 513 | FI 2 | 97.26 |
| Boron Compounds in Chemistry | Lifetime | 191 | FI 3 | 95.74 |
| Global Cancer Incidence and Screening | Lifetime | 790 | FI 7 | 96.67 |
| Proteoglycans and glycosaminoglycans research | Lifetime | 518 | FI 13 | 95.49 |
| BRCA gene mutations in cancer | Lifetime | 748 | FI 8 | 95.67 |
| Advanced Breast Cancer Therapies | Lifetime | 551 | FI 1 | 95.72 |
| Soft tissue tumors and treatment | Lifetime | 88 | FI 1 | 94.65 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 413 | FI 3 | 92.80 |
| Multiple and Secondary Primary Cancers | Lifetime | 833 | FI 11 | 92.55 |
| Lymphatic System and Diseases | Lifetime | 553 | FI 17 | 90.53 |
| Gastrointestinal disorders and treatments | 2021-2025 | 18 | FI 1 | 98.22 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 45 | FI 1 | 98.24 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 679 | FI 1 | 95.15 |
| HER2/EGFR in Cancer Research | 2021-2025 | 509 | FI 1 | 91.65 |
